Network origin in Richard Hennings first degree
Entity | Entity type | Industry | |
---|---|---|---|
Public Company | Pharmaceuticals: Major | 18 | |
Public Company | Pharmaceuticals: Major | 13 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Richard Hennings via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
CHARLES & COLVARD, LTD. | Other Consumer Specialties | Director of Finance/CFO | |
NEUROCRINE BIOSCIENCES, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Synairgen Research Ltd.
Synairgen Research Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Synairgen Plc, Synairgen Research Ltd. is a British company that engages in respiratory biology and develops novel therapies. The company is based in Southampton, UK. Synairgen Research was founded in 2003. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
Respironics Ltd.
Respironics Ltd. Financial ConglomeratesFinance Respironics Ltd. develops and manufactures medical and healthcare products. Its products include Porta-Neb, Freeway Freedom, Sidestream, and Ventstream. The company was founded in 1977 and is headquartered in Bognor Regis, the United Kingdom. | Financial Conglomerates | Chief Operating Officer Corporate Officer/Principal Director of Finance/CFO | |
Organon Pharma (UK) Ltd.
Organon Pharma (UK) Ltd. Pharmaceuticals: MajorHealth Technology Organon Pharma (UK) Ltd. develops and manufactures pharmaceuticals. It offers osteoarthritis pain treatment Arcoxia, cardiovascular medication Cozaar, HIV drug Crixivan and asthma treatment Singulair. It operates a research center specializing in the development of central nervous system disorder such as Alzheimer's disease, depression, anxiety and migrane. The company was founded in 1953 and is headquartered in Hoddesdon, the United Kingdom. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
The University of Southampton | College/University | Corporate Officer/Principal Undergraduate Degree | |
DOVA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Chief Executive Officer | |
University of London | College/University | Doctorate Degree Graduate Degree | |
The University of Manchester | College/University | Doctorate Degree Undergraduate Degree | |
TranScrip Partners LLP
TranScrip Partners LLP Pharmaceuticals: MajorHealth Technology TranScrip Partners LLP is a consultancy provider for biotech and pharmaceutical companies. TranScrip Partners was founded in 2008 and is based in Wokingham, UK. The British company offers development and commercialization services to its clients. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
MedImmune Ltd.
MedImmune Ltd. BiotechnologyHealth Technology MedImmune Ltd. engages in research, development and exploitation of products in the field of molecular engineering. The company was founded on December 11, 1989 and is headquartered in Cambridge, the United Kingdom. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
University of Michigan | College/University | Undergraduate Degree Doctorate Degree | |
The Royal College of Physicians | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
Akamis Bio Ltd.
Akamis Bio Ltd. BiotechnologyHealth Technology Akamis Bio Ltd. operates as a biotechnology company which develops novel therapeutics that addresses cancer and other clinically unmet diseases. Its products include Enadenotucirev, Espindolol and AbEnAd. The firm also develops treatments based upon the research phase vaccine platform PolySTAR, which combines recombinant viral vectors with polymers to shield them from the immune system, and the research phase adjuvant and immunotherapeutic platform PolyMAP, which combines polymers with synthetic adjuvants to significantly enhance the effectiveness of vaccines. The company was founded by Andrew Justin Stewart Coats and Stefan D. Anker on November 17, 2006 and is headquartered in Abingdon, the United Kingdom. | Biotechnology | Director of Finance/CFO | |
RioTech Pharmaceuticals Ltd.
RioTech Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology RioTech Pharmaceuticals Ltd. develops novel therapeutic drugs for hepatitis C virus. The company was founded on Nov 5, 2001 by Graham Foster, Adrian V. S. Hill, Peter Karayiannis, Howard David Thomas and Mark R. Thursz and is headquartered in Horsham, the United Kingdom. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Hybrid BioSystems Ltd.
Hybrid BioSystems Ltd. Miscellaneous Commercial ServicesCommercial Services Hybrid is an Oxford Biotechnology Company focused on revolutionizing viral vaccines with its patented vaccine delivery technologies. Hybrid has an established and well equipped laboratory located at Cherwell Innovation Centre in Oxford shire, which houses both its corporate research facility and contract research services. Using a mixed product and platform business model it is developing its in-house lead products towards phase I/II proof of concept clinical trials as well as furthering its partnerships with leading pharmaceutical and biotechnology companies. Hybrid's experienced scientific and management team has reached this late stage of development through a highly efficient use of grant funding and revenues, together with minimal seed funding. With its unparalleled expertise in the field of viral steal thing technologies, The firm is also able to offer general and bespoke virology services, including high-quality adenovirus production and purification. Hybrid BioSystems uses iLabber electronic lab books for maximum IP protection and secure data storage. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
PricewaterhouseCoopers LLP
PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Chronos Therapeutics Ltd.
Chronos Therapeutics Ltd. BiotechnologyHealth Technology Chronos Therapeutics Ltd. manufactures drugs. It pursuing innovative therapeutics for age-related diseases through the joint efforts of experts in medical research, drug discovery and business development. The company was founded in 2009 and is headquartered in Oxford, the United Kingdom. | Biotechnology | Director/Board Member | |
MISSION Therapeutics Ltd.
MISSION Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology MISSION Therapeutics Ltd. develops small molecule drugs targeting enzymes involved in cancer and other diseases. It focuses on selectively targeting deubiquitylating enzymes to treat cancer, neurodegenerative and other diseases. The company was founded by Stephen Jackson Philip, Xavier Jacq, Niall M. B. Martin and Keith Menear in 2011 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Director of Finance/CFO | |
Parke-Davis & Co. Ltd.
Parke-Davis & Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of Pfizer Inc., Parke-Davis & Co. Ltd. is a British pharmaceutical company. The company is based in St. Helier, UK. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Crescendo Biologics Ltd.
Crescendo Biologics Ltd. Miscellaneous Commercial ServicesCommercial Services Crescendo Biologics Ltd. engages in the development of new medicines based on antibody fragment technology. Its products in pipeline in dermatology include CB001, a transformational Humabody-based topical biologic for psoriasis which combines exceptional activity against a validated target with a topical route of delivery to avoid systemic side effects. The firm?s oncology products in pipeline include Humabody Multi-Specific T-Cell Engagers, Humabody Antibody Drug Conjugates and Immune Checkpoint Inhibitors. The company was founded by Michael Anthony Romanos, David Rayll Brown and John Bradshaw on November 13, 2007 and is headquartered in Cambridge, the United Kingdom. | Miscellaneous Commercial Services | Chief Executive Officer | |
SOLGOLD PLC | Precious Metals | Director of Finance/CFO | |
IOFINA PLC | Chemicals: Specialty | Corporate Secretary | |
BRIGHTLANE CORP. | Real Estate Development | Director/Board Member | |
University of Lancaster | College/University | Graduate Degree | |
MUSTANG ENERGY PLC | Financial Conglomerates | Director/Board Member | |
Kerman & Co. LLP
Kerman & Co. LLP Miscellaneous Commercial ServicesCommercial Services Kerman & Co. LLP operates as a corporate and commercial law firm. It provides legal services related to employment, immigration, private wealth, real estate, and dispute resolution. The company was founded by Andy Kerman and Daniel O’Connell in 1998 and is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Opterion Health AG
Opterion Health AG Medical/Nursing ServicesHealth Services Opterion Health AG is a Swiss company that focuses on bringing innovation to dialysis care and fostering home dialysis to improve the quality of life for patients suffering from end-stage renal disease (ESRD). Opterion Health is based in Muttenz, CH. The private company aims to increase the survival rates of people with ESRD and reduce healthcare costs. The company was founded in 2012 by Guido Grentzmann, and the CEO is Bjorn Englund. | Medical/Nursing Services | Director/Board Member | |
IP GROUP PLC | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
University of Wisconsin-Milwaukee | College/University | Undergraduate Degree | |
ALSP ORCHID ACQUISITION CORPORATION I | Financial Conglomerates | Director/Board Member | |
Southampton Asset Management Ltd.
Southampton Asset Management Ltd. Investment ManagersFinance Southampton Asset Management Ltd (SAM) is a venture capital firm, a subsidiary of University of Southampton Holdings Ltd. The firm is headquartered in Southampton, United Kingdom. | Investment Managers | Director/Board Member | |
Abingworth Management Ltd.
Abingworth Management Ltd. Investment ManagersFinance Abingworth Management Ltd. operates as an investment firm with interests in the life sciences and healthcare sectors. It offers services for businesses in all stages of company development, including early and late-stage venture financing, growth equity, and public companies. The company was founded in 1973 and is headquartered in London, the United Kingdom. | Investment Managers | Investor Relations Contact | |
University of Kent | College/University | Undergraduate Degree | |
PJB Publications Ltd.
PJB Publications Ltd. Publishing: Books/MagazinesConsumer Services Part of Informa Plc, PJB Publications Ltd. publishes international business news and provides information services. The company is based in Richmond, UK. PJB Publications was acquired by Informa Switzerland Ltd. on December 02, 2003 for $206.72 million. | Publishing: Books/Magazines | Corporate Officer/Principal | |
Proximagen Group Plc
Proximagen Group Plc Miscellaneous Commercial ServicesCommercial Services Proximagen Group Plc engages in the business of discovery and development of therapeutic treatments. The company was founded by Jenner Peter on November 2003 and is headquartered in Cambridge, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
iQur Ltd.
iQur Ltd. BiotechnologyHealth Technology iQur Ltd. develops vaccines based on tandem core vaccine technology. The firm offers fibrosis assessment in viral hepatitis and other chronic liver diseases, and developing new treatments for serious liver disease through drug discovery research programs. The company was founded by William Rosenberg on February 13, 2003 and is headquartered in London, the United Kingdom. | Biotechnology | Chairman | |
University of Portsmouth | College/University | Corporate Officer/Principal | |
Drug Information Association
Drug Information Association Miscellaneous Commercial ServicesCommercial Services The Drug Information Association is a non-profit multidisciplinary association that operates to promote health and well-being. The non-profit company is based in Horsham, PA. Marwan Fathallah has been the CEO of the company since 2023. | Miscellaneous Commercial Services | Chairman |
Statistics
International
United Kingdom | 30 |
United States | 12 |
Israel | 2 |
Switzerland | 2 |
Cayman Islands | 2 |
Sectoral
Health Technology | 15 |
Consumer Services | 11 |
Commercial Services | 10 |
Finance | 7 |
Consumer Durables | 2 |
Operational
Director/Board Member | 104 |
Corporate Officer/Principal | 69 |
Director of Finance/CFO | 35 |
Chief Tech/Sci/R&D Officer | 15 |
Chief Executive Officer | 14 |
Most connected contacts
Insiders | |
---|---|
Martin Edwards | 38 |
Stephen Holgate | 24 |
Piers John Morgan | 18 |
Joseph Colliver | 16 |
Simon Holden | 16 |
David Moskowitz | 15 |
Simon Shaw | 14 |
Iain Peter Murray Buchanan | 13 |
Mark Hahn | 13 |
Felicity Gabbay | 11 |
David Zaccardelli | 10 |
Theodora Caroline Harold | 10 |
Kenneth B. Newman | 9 |
David Campbell | 9 |
Jan-Anders Karlsson | 8 |
- Stock Market
- Insiders
- Richard Hennings
- Company connections